Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
((Chloroquine OR Hydroxychloroquine) AND ("Novel Coronavirus" OR COVID-19 OR SARS-CoV-2 OR 2019-nCoV))
2,863 results
  • Assessment and management of asymptomatic COVID-19 infection: A Systematic Review. [Review]
    Travel Med Infect Dis. 2021 Apr 07 [Online ahead of print]Barboza JJ, Chambergo-Michilot D, … Rodriguez-Morales AJ
  • CONCLUSIONS: There is no standard treatment for asymptomatic COVID-19 individuals. There are no studies of adequate design to make this decision. It has been shown that most asymptomatic individuals who were followed have recovered, but this cannot be attributed to standard treatment.
  • Clinical Features and Prognostic Factors of 245 Portuguese Patients Hospitalized With COVID-19. [Journal Article]
    Cureus. 2021 Mar 04; 13(3):e13687.Salvador P, Oliveira P, … Malheiro L
  • Introduction Since the declaration of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in March 2020, Portugal was considered a role model with regards to the first COVID-19 wave. However, a third wave started in 2021 started, turning the country into the worst in the world regarding new infections and death rate per capita in the last weeks of January 2021. No significan…
  • The anti-scientists bias: The role of feelings about scientists in COVID-19 attitudes and behaviors. [Journal Article]
    J Appl Soc Psychol. 2021 Feb 16 [Online ahead of print]Sanchez C, Dunning D
  • Across three studies, we investigated who expresses concern for COVID-19, or coronavirus, and engages in behaviors that are consistent with slowing the spread of COVID-19. In Studies 1 and 2 (n = 415, n = 199), those with warmer feelings toward scientists were more concerned and engaged in greater COVID-preventative behaviors, regardless of partisanship. That is, an anti-scientists bias was relat…
  • Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis. [Journal Article]
    Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):219-226.Faruqui AR, Xavier D, … Kshirsagar NA
  • CONCLUSIONS: HCQ prophylaxis first dose was well tolerated among HCWs as evidenced by a low discontinuation. For adverse effects, a small number required treatment, and none required hospitalization. The study had limitations of convenience sampling and lack of laboratory and electrocardiography confirmation of AEs.
  • Drugs intervention study in COVID-19 management. [Review]
    Drug Metab Pers Ther. 2021 Apr 05 [Online ahead of print]Taher M, Tik N, Susanti D
  • By 9 February 2021, the Coronavirus has killed 2,336,650 people worldwide and it has been predicted that this number continues to increase in year 2021. The study aimed to identify therapeutic approaches and drugs that can potentially be used as interventions in Coronavirus 2019 (COVID-19) management. A systematic scoping review was conducted. Articles reporting clinical evidence of therapeutic m…
  • Network bioinformatics analysis provides insight into drug repurposing for COVID-19. [Journal Article]
    Med Drug Discov. 2021 Mar 30 [Online ahead of print]Li X, Yu J, … Wang W
  • The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles, which can rapidly enter clinical trials. In this study, we present a novel network-based drug repurposing platform to id…
  • An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity. [Review]
    Viruses. 2021 03 26; 13(4)Zhang Y, Gargan S, … Stevenson NJ
  • Coronaviruses are a large family of zoonotic RNA viruses, whose infection can lead to mild or lethal respiratory tract disease. Severe Acute Respiratory Syndrome-Coronavirus-1 (SARS-CoV-1) first emerged in Guangdong, China in 2002 and spread to 29 countries, infecting 8089 individuals and causing 774 deaths. In 2012, Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) emerged in Saudi Arabia …
New Search Next